Skip to main content

Dave Muoio

By Dave Muoio | 05:00 pm | September 22, 2020
Although still a work in progress, the new center will reportedly help coordinate digital health projects within the agency while providing expertise to external stakeholders.
By Dave Muoio | 03:54 pm | September 21, 2020
Also: Hospital and health system software maker Olive closes $106 million; Ready's tech-enabled on-demand home care locks up $54 million.
By Dave Muoio | 05:34 pm | September 18, 2020
Contact tracing apps, symptom checkers and other data-driven tools provide tangible benefits, but experts say that more can be done to educate individuals on what information they collect and how it's handled.
By Dave Muoio | 04:35 pm | September 17, 2020
Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders.
By Dave Muoio | 11:07 am | September 17, 2020
A new analysis of published RCTs did see significant benefits among short-term and single-focus app interventions, but noted that "relatively few high-quality studies have been conducted" in this area.
By Dave Muoio | 04:35 pm | September 16, 2020
Activist short seller Citron Research called the Israeli digital X-ray company out on its limited R&D expenditure, suspicious distribution agreements and other factors. Nanox has described the report as incorrect and misleading.
By Dave Muoio | 04:15 pm | September 15, 2020
In a recent survey, 67% of consumers and 91% of IT professionals said they'd support a nationwide rollout of contact-tracing apps or other technologies.
By Dave Muoio | 12:48 pm | September 15, 2020
The company has raised a lifetime total of $50 million.
By Dave Muoio | 12:37 pm | September 14, 2020
With these funds, the telehealth company said it will be expanding platform and launching new supporting products and services.
By Dave Muoio | 05:53 pm | September 11, 2020
The companies will be collaborating on a prescription digital therapeutic for patients with schizophrenia built on Click Therapeutics' tech platform.